Table 1 Characterization of cohort 1.
Age | ||
|---|---|---|
Average (range) | 68 (38; 94) | |
Sex | N | % of total |
|---|---|---|
Female | 46 | 25.7% |
Male | 132 | 74.3% |
Primary tumor (location) | N | % of total |
|---|---|---|
Control | 31 | 19.0% |
BCa | 136 | 81.0% |
Tumor stage | N | % of total |
|---|---|---|
Control | 31 | – |
min.pT1 | 38 | 26.0% |
min.pT2 | 40 | 27.0% |
min.pT3 | 45 | 31.0% |
min.pT4 | 24 | 16.0% |
Tumor type | N | % of total |
|---|---|---|
Control | 31 | – |
Non-muscle invasive (NMIBC) | 38 | 26.0% |
Muscle invasive (MIBC) | 109 | 74.0% |
Survival time (months) | ||
|---|---|---|
Median (range) | 50 (1; 283) | |
CDCP1 level | N | % of total |
|---|---|---|
Low | 115 | 78.3% |
High | 32 | 21.7% |
